Status: retired, Primitive. Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3682048014 | Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
3682049018 | Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Is a | Metformin and pioglitazone only product in oral dose form | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Is a | Metformin- and pioglitazone-containing product | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Pioglitazone | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Metformin | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Thiazolidinedione | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Is a | Metformin-containing product in oral dose form | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has BoSS | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has BoSS | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator value | 15 | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Metformin | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has active ingredient | Pioglitazone | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has precise active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Is a | Metformin- and pioglitazone-containing product in oral dose form | false | Inferred relationship | Some | ||
Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set